Dofetilide
Sponsors
ProRhythm, Inc., Food and Drug Administration (FDA), Gilead Sciences, Samir Saba
Conditions
Atrial FibrillationDrug-induced QT ProlongationDrug-induced Surface ECG ChangesLong QT SyndromePharmacodynamicsPharmacokinetics
Phase 1
Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
CompletedNCT01873950
Start: 2013-05-31End: 2014-12-31Updated: 2018-03-08
Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block
CompletedNCT02308748
Start: 2014-05-31End: 2014-06-30Updated: 2016-06-08
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
CompletedNCT02365532
Start: 2015-02-28End: 2015-05-31Updated: 2015-05-20